TSE:PRN

Profound Medical - PRN Stock Forecast, Price & News

C$12.64

+0.45 (+3.69%)

(As of 03/24/2023 12:00 AM ET)

Add

Compare

Today's Range: C$12.01
▼
C$12.64
50-Day Range: C$12.19
▼
C$18.00
52-Week Range: C$4.21
▼
C$18.33

Volume: 3,200 shs
Average Volume: 22,125 shs
Market Capitalization: C$264.30 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Profound Medical (TSE:PRN) Stock

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

Receive PRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter.

PRN Stock News Headlines

March 23, 2023 | americanbankingnews.com

Profound Medical Corp. Expected to Post Q1 2023 Earnings of ($0.36) Per Share (TSE:PRN)

October 15, 2022 | marketwatch.com

Profound Medical to Release Third Quarter 2022 Financial Results on November 3 - Conference Call to Follow

March 26, 2023 | Stansberry Research (Ad)

The gold catalyst we’ve waited for

If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.

October 13, 2022 | finance.yahoo.com

Profound Medical to Release Third Quarter 2022 Financial Results on November 3 – Conference Call to Follow

September 4, 2022 | marketwatch.com

Profound Medical Provides TULSA-PRO(R) Reimbursement Update

August 30, 2022 | nz.finance.yahoo.com

We're Hopeful That Profound Medical (TSE:PRN) Will Use Its Cash Wisely

August 4, 2022 | finance.yahoo.com

Profound Medical Announces Second Quarter 2022 Financial Results

June 16, 2022 | finance.yahoo.com

Profound Medical to Participate in the Cowen 7th Annual FutureHealth Conference

March 26, 2023 | Stansberry Research (Ad)

The gold catalyst we’ve waited for

May 18, 2022 | finance.yahoo.com

Profound Medical Clarifies Recent Insider Buying

March 4, 2022 | finance.yahoo.com

Companies Like Profound Medical (TSE:PRN) Are In A Position To Invest In Growth

January 18, 2022 | finance.yahoo.com

Bullish Profound Medical Corp. (TSE:PRN) insiders filled their treasuries with US$782k worth of stock over last year

October 28, 2021 | finance.yahoo.com

Will Profound Medical (PROF) Report Negative Earnings Next Week? What You Should Know

October 4, 2021 | finance.yahoo.com

Profound Medical (TSE:PRN) shareholders have earned a 41% CAGR over the last three years

September 8, 2021 | finance.yahoo.com

Profound Medical to Participate in September Virtual Investor Conferences

July 28, 2021 | finance.yahoo.com

PROFOUND MEDICL (PROF) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

April 14, 2021 | finance.yahoo.com

Profound Medical to Participate in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference

March 1, 2021 | msn.com

Victorian mental health royal commission final report finds system operates in crisis mode

February 28, 2021 | msn.com

Notre Dame nation mourns the death of former football star Louis Nix III

February 24, 2021 | nytimes.com

On the Front Lines of Diplomacy, but at the Back of the Vaccine Queue

February 22, 2021 | msn.com

Robert Jorvig, first Metropolitan Council head, dies at 99

February 21, 2021 | wsj.com

‘Mr. Humble and Dr. Butcher’ Review: A Heart in the Right Place

February 18, 2021 | msn.com

Full Transcript: San Diego State of the County Address 2021

January 30, 2021 | marketwatch.com

Global Medical Pressure Transducers Market 2020 Manufacturer Analysis, Technology Advancements, Industry Scope and Forecast to 2025

January 20, 2021 | marketwatch.com

Medical Mobility Aid Device Market Research Report Includes Size, Capacity, Production, Revenue, Gross Margin, Forecast to 2026

January 8, 2021 | marketwatch.com

Medical Software Market Size is Estimated to Accelerate at CAGR of 6.63% Industry Segmentation by Companies, Types and Application 2021 to 2025

January 1, 2021 | finance.yahoo.com

A Look At The Fair Value Of Profound Medical Corp. (TSE:PRN)

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive PRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter.

PRN Company Calendar

Today: 3/26/2023
Next Earnings (Estimated): 5/08/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Diagnostics & Research
Sub-Industry: N/A
Sector: Medical
Current Symbol: TSE:PRN
CUSIP: N/A
CIK: N/A
Web: www.profoundmedical.com
Phone: 647-476-1350
Fax: N/A
Employees: 146
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($1.75)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-28,670,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -43.23%
Return on Assets: -24.47%

Debt

Debt-to-Equity Ratio: 15.83
Current Ratio: 14.82
Quick Ratio: 14.98

Sales & Book Value

Annual Sales: C$6.68 million
Price / Sales: 39.57
Cash Flow: C$3.89 per share
Price / Cash Flow: 3.25
Book Value: C$2.49 per share
Price / Book: 5.08

Miscellaneous

Outstanding Shares: 20,910,000
Free Float: N/A
Market Cap: C$264.30 million
Optionable: Optionable
Beta: 1.23

Key Executives

Dr. Arun Swarup Menawat MBA (Age 68)
Ph.D., Chairman & CEO
Comp: $3.08M

Mr. Rashed Dewan (Age 55)
Chief Financial Officer
Comp: $198.13k

Dr. Mathieu Burtnyk (Age 41)
Sr. VP of Product Leader TULSA-PRO
Comp: $221.27k

Mr. Stephen Kilmer
Investor Relations

Mr. Hartmut Warnken
Chief Commercial Officer of OUS

Mr. Jacques F. Cornet (Age 67)
Sr. VP & Product Leader Sonalleve

Mr. Abbey Goodman
Chief Commercial Officer of US

Mr. Matthew Sobczyk C.A.
CPA, Assistant Corp. Controller

Mr. Levant Tinaz
Software Developer

Key Competitors

View All Competitors

PRN Stock - Frequently Asked Questions

How have PRN shares performed in 2023?: Profound Medical's stock was trading at C$14.48 at the beginning of 2023. Since then, PRN shares have decreased by 12.7% and is now trading at C$12.64.
View the best growth stocks for 2023 here.
When is Profound Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our PRN earnings forecast.
What other stocks do shareholders of Profound Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Profound Medical investors own include Orocobre (ORL), Ballard Power Systems (BLDP), Whitecap Resources (WCP), Alcanna (CLIQ), Just Energy Group (JE), Kezar Life Sciences (KZR), Lithium Americas (LAC), Russel Metals (RUS) and Absolute Software Co. (ABT.TO) (ABT).
What is Profound Medical's stock symbol?: Profound Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "PRN."

How do I buy shares of Profound Medical?: Shares of PRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Profound Medical's stock price today?: One share of PRN stock can currently be purchased for approximately C$12.64.
How much money does Profound Medical make?: Profound Medical (TSE:PRN) has a market capitalization of C$264.30 million and generates C$6.68 million in revenue each year. The company earns C$-28,670,000.00 in net income (profit) each year or C($1.75) on an earnings per share basis.
How many employees does Profound Medical have?: The company employs 146 workers across the globe.
How can I contact Profound Medical?: The official website for the company is www.profoundmedical.com. The company can be reached via phone at 647-476-1350.

This page (TSE:PRN) was last updated on 3/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial